Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, Hongwei Cheng, Gian Luca Negri, Melvin Pan, Xue Qi Wang, Alberto Delaidelli, Bo Rafn, Jordan Cran, Fan Zhang, Haifeng Zhang, Shane Colborne, Martin Gleave, Anna Mandinova, Nancy Kedersha, Christopher S Hughes

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHistone Deacetylase Inhibitors Research · Peptidase Inhibition and Analysis · Protein Degradation and Inhibitors
Correction to: EMBO Reports (2019) 20:e48375. 10.15252/embr.201948375 | Published online 31 October 2019
The journal contacted the authors after becoming aware of a potential image aberration in the paper. Based on the exchanges and data provided by the authors, the journal retracts and replaces the following figure panels. Corresponding original images are published with this notice:
Figure 5A is retracted and replaced.
Figure 5A Original.
Figure 5ACorrected.Source data are available online for this figure.
Figure 5A source data is published with this correction.
Author statement:
We identified an error in Figure 5A where an image from tumor T2 was mistakenly placed under tumor T3 (both from the MS-275 group). This error occurred during the selection of images from .ppt files used for publication. Importantly, this mistake does not affect data analysis, as the original images were correctly stored and analyzed separately for each tumor. The error occurred within the same treatment group and was an inadvertent oversight.
This author correction does not affect the conclusions of the manuscript.
A.M.El-Naggar, S.P.Somasekharan, Y.Wang, G.L.Negri, M. Pan, X.Q.Wang, A.Delaidelli, B.Rafn, J.Cran, F.Zhang, H.Zhang, M.Gleave, A.Mandinova, C.S.Hughes, O.Delattre, Y.Wang, D.G.Huntsman, G.B.Morin and P.H.Sorensen agree to this author correction. No response could be obtained from H.Cheng, N.Kedersha, S.Colborne and D.Surdez.
Supplementary information
Figure 5A Source Data
